Revolver Therapeutics has raised £572,000 to develop therapies for untreatable cancer targets. The funding round was led by QantX, with follow-on investment from UKI2S and the University of Bath.
Amount Raised
£572,000
Round Type
Seed
BathBiotechnologyHealth CareTherapeuticsInvestors
Description
A University of Bath spin-out, Revolver Therapeutics, is developing treatments for previously untreatable cancer targets. The recent funding aims to support therapies that inhibit transcription factors, which drive tumor growth. The funding round was led by QantX, with additional investment from UKI2S and the University of Bath. This funding will help advance their innovative approach to cancer treatment.
Quick answer
Revolver Therapeutics raised £572,000 in a Seed round, dated July 6, 2026. Investors: University Of Bath, Qant X, UK Innovation & Science Seed Fund, Future Planet Capital and QantX. Revolver Therapeutics is based in Bath, England, United Kingdom.
- How much did Revolver Therapeutics raise?
- Revolver Therapeutics raised £572,000 in a Seed round on July 6, 2026.
- Who invested in Revolver Therapeutics?
- University Of Bath, Qant X, UK Innovation & Science Seed Fund, Future Planet Capital and QantX are named as investors in this round.
- What does Revolver Therapeutics do?
- Revolver Therapeutics is a University of Bath spin-out focused on developing treatments for previously untreatable cancer targets.
- Where is Revolver Therapeutics based and how big is it?
- Revolver Therapeutics is based in Bath, England, United Kingdom. Fundz records about 4 employees.
Source: Fundz verified event record.
Who else raised in Therapeutics and Biotechnology around the same time
Companies in the same sectors as Revolver Therapeutics that raised within 45 days of this round, from Fundz verified event records.
- Amylyx Pharmaceuticals raised $500M (Post-IPO Equity) on August 20, 2026.
- Kynexis raised $46M (Series A) on August 19, 2026.
- Abcuro raised $66M (Series D) on August 18, 2026.
- bioAffinity Technologies raised $4M (Post-IPO Equity) on August 14, 2026.
- Apollomics raised $10M on August 14, 2026.
- Khartis Therapeutics raised $50M (Series B) on August 13, 2026.
Who to call at Revolver Therapeutics, and when
A new round usually means Revolver Therapeutics is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Revolver Therapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Revolver Therapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Revolver Therapeutics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Revolver Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Revolver Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.